Metraipolis › archive › dc_2f4f89b593df

Semi-Quantitative Evaluation of BRCA1 Protein in Breast Tumors Using Anti-BRCA1 Antibodies: Clinical Implications — Europe PMC PMID:41751865

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41751865
DOI
10.3390/ijms27041729
License (as archived)
solo-consultazione
Archived
2026-11-05T22:47:24.417Z
SHA-256 of the archived text
ee5d11d976bc5cb677884ed5bd5f6e82c3597e7c821d0cb19ab58e3065393c49
Stable URL of this page
https://metraipolis.com/documento/dc_2f4f89b593df

How to cite

Semi-Quantitative Evaluation of BRCA1 Protein in Breast Tumors Using Anti-BRCA1 Antibodies: Clinical Implications — Europe PMC PMID:41751865 — Europe PMC (en), https://europepmc.org/article/MED/41751865 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f4f89b593df (Metraipolis archive dc_2f4f89b593df, sha256 ee5d11d976bc5cb677884ed5bd5f6e82c3597e7c821d0cb19ab58e3065393c49)
BibTeX
@misc{dc2f4f89b593df,
  title = {Semi-Quantitative Evaluation of BRCA1 Protein in Breast Tumors Using Anti-BRCA1 Antibodies: Clinical Implications — Europe PMC PMID:41751865},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41751865},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f4f89b593df; sha256 ee5d11d976bc5cb677884ed5bd5f6e82c3597e7c821d0cb19ab58e3065393c49},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751865. Agents can read the archived copy with the MCP tool read_document.